1. Home
  2. Research
  3. Centers & Labs
  4. RIKEN Center for Integrative Medical Sciences

RIKEN Center for Integrative Medical Sciences Laboratory for Genotyping Development

Team Leader: Yukihide Momozawa (D.V.M., Ph.D.)

Research Summary

Yukihide  Momozawa(D.V.M., Ph.D.)

Since our laboratory was founded in 2000, we have performed a large-scale genetic analysis to realize personalized medicine based on the individual difference in genome DNA. In the beginning, we contributed to the success for the International HapMap Project. Since 2005, our team had worked as a main facility of genetic research to perform genome wide association studies of various complex diseases for the BioBank Japan project. Recently, we have focused on rare variants with a large effect on disease risk and studied on hereditary cancer. Our hope is to implement genomic medicine to optimize medical care by use of genetic information.

Main Research Fields

  • Medicine, Dentistry & Pharmacy

Related Research Fields

  • Agricultural Sciences


  • Genome
  • Complex disease
  • Next generation sequencer
  • Rare variants

Selected Publications

Papers with an asterisk(*) are based on research conducted outside of RIKEN.

  • 1.Momozawa Y, Sasai R, Usui Y, Shiraishi K, Iwasaki Y, Taniyama Y, Parsons M T., Mizukami K, Sekine Y, Hirata M, Kamatani Y, Endo M, Inai C, Takata S, Ito H, Kohno T, Matsuda K, Nakamura S, Sugano K, Yoshida T, Nakagawa H, Matsuo K, Murakami Y, Spurdle A B., Kubo M.:
    "Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants"
    JAMA Oncol. (2022)
  • 2.Hashimoto M, Saito Y, Nakagawa R, Ogahara I, Takagi S, Takata S, Amitani H, Endo M, Yuki H, Ramilowski J A., Severin J, Manabe R, Watanabe T, Ozaki K, Kaneko A, Kajita H, Fujiki S, Sato K, Honma T, Uchida N, Fukami T, Okazaki Y, Ohara O, Shultz L D., Yamada M, Taniguchi S, Vyas P, De Hoon M, Momozawa Y, Ishikawa F.:
    "Combined inhibition of XIAP and BCL2 drives maximal therapeutic efficacy in genetically diverse aggressive acute myeloid leukemia"
    Nature Cancer. 2: 340-356 (2021)
  • 3.Saiki R, Momozawa Y, Nannya Y, Nakagawa M M., Ochi Y, Yoshizato T, Terao C, Kuroda Y, Shiraishi Y, Chiba K, Tanaka H, Niida A, Imoto S, Matsuda K, Morisaki T, Murakami Y, Kamatani Y, Matsuda S, Kubo M, Miyano S, Makishima H, Ogawa S.:
    "Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis"
    Nature Medicine. 27: 1239-1249 (2021)
  • 4.Mizukami K, Iwasaki Y, Kawakami E, Hirata M, Kamatani Y, Matsuda K, Endo M, Sugano K, Yoshida T, Murakami Y, Nakagawa H, Spurdle A B., Momozawa Y.:
    "Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genes"
    EBioMedicine. 60: 103033 (2020)
  • 5.Motegi T, Kochi Y, Matsuda K, Kubo M, Yamamoto K, Momozawa Y.:
    "Identification of rare coding variants in TYK2 protective for rheumatoid arthritis in the Japanese population and their effects on cytokine signalling"
    Ann Rheum Dis. 78: 1062-1069 (2019)
  • 6.Momozawa Y, Iwasaki Y, Parsons MT, Kamatani Y, Takahashi A, Tamura C, Katagiri T, Yoshida T, Nakamura S, Sugano K, Miki Y, Hirata M, Matsuda K, Spurdle A B., Kubo M.:
    "Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls"
    Nat Commun. 9: 4083 (2018)
  • 7.Momozawa Y, Akiyama M, Kamatani Y, Arakawa S, Yasuda M, Yoshida S, Oshima Y, Mori R, Tanaka K, Mori K, Inoue S, Terasaki H, Yasuma T, Honda S, Miki A, Inoue M, Fujisawa K, Takahashi K, Yasukawa T, Yanagi Y, Kadonosono K, Sonoda K, Ishibashi T, Takahashi A, Kubo M.:
    "Low-frequency coding variants in CETP and CFB are associated with susceptibility of exudative age-related macular degeneration in the Japanese population"
    Hum Mol Genet. 25: 5027-5034 (2016)
  • 8.Arakawa S, Takahashi A, Ashikawa K, Hosono N, Aoi T, Yasuda M, Oshima Y, Yoshida S, Enaida H, Tsuchihashi T, Mori K, Honda S, Negi A, Arakawa A, Kadonosono K, Kiyohara Y, Kamatani N, Nakamura Y, Ishibashi T, Kubo M.:
    "Genome-wide association study identifies two susceptibility loci for exudative age-related macular degeneration in the Japanese population"
    Nat Genet. 43: 1001-4 (2011)
  • 9.Kubo M, Hata J, Ninomiya T, Matsuda K, Yonemoto K, Nakano T, Matsushita T, Yamazaki K, Ohnishi Y, Saito S, Kitazono T, Ibayashi S, Sueishi K, Iida M, Nakamura Y, Kiyohara Y.:
    "A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction."
    Nat Genet. 39: 212-7 (2007)
  • 10.The International HapMap Consortium.:
    "A haplotype map of the human genome"
    Nature. 437: 1299-320 (2005)

Recent Research Results

Related Links

Lab Members

Principal investigator

Yukihide Momozawa
Team Leader

Core members

keijiro Mizukami
Research Scientist
Takashi Watanabe
Technical Scientist
Yoshiaki Usui
Postdoctoral Researcher
Hanae Iijima
Expert Technician
Yoshiki Mochizuki
Expert Technician
Yusuke Iwasaki
Senior Technical Staff
Sadaaki Takata
Technical Staff I
Tomomi Aoi
Technical Staff II
Mikiko Endo
Technical Staff II
Mitsuyo Yamaguchi
Technical Staff II
Rumi Sasai
Technical Staff II
Ryoko Yamada
Visiting Scientist
Yuya Sekine
Student Trainee

Contact Information

1-7-22 Suehiro-cho, Tsurumi-ku,
Yokohama City, Kanagawa,
230-0045, Japan
Email: momozawa [at] riken.jp